Antibiotic resistance and the development of novel antibiotics were, unsurprisingly, major topics atECCMID 2017.Dilip Nathwani’skeynote lecture onantibiotic stewardship around the globehighlighted the need to extend the life of existing antibiotics as well as developing new ones. Novel innovations, such as India’sred line campaign, to reduce antibiotic consumption and thestrides made by Mexico and Brazilin reducing their consumption were discussed.
Nobel prize winnerFrançoise Barré-Sinoussigave her thoughts onwhat is left to be done to end the HIV epidemic. Although great progress has been made, since the discovery of HIV in the 1980s, in the treatment of AIDS and in reducing the spread of infections much more needs to be done. She particularly highlighted the need for basic science to underpin clinical research and the need to understand non-AIDS-related mortality in HIV-infected individuals.
Emerging viruses, such as Zika and Ebola were the focus of a number of talks withJanet Scottdiscussing the difficulties faced by Ebola survivors, many of who suffer from mobility and ocular issues. Do we need to consider these conditions when providing therapy during the acute phase of illness, and could sepsis experts help?
Zeno Bisoffimade animpassioned plea为诊断和treatm更大的资源ent of strongyloidiasis and encouraged involvement with theStongNetworking group. It will be interesting to see the results of theongoing systematic reviewthat will provide information on the accuracy of
molecular biology techniques for the diagnosis ofStrongyloides stercoralisinfection.
FinallyDavid Pridegave afascinating talkon the human respiratory virome and highlighted the differences in viral communities in health and disease states. Do these changes drive disease or are the viruses bystanders?
The talks provoked as many questions as answers and made it clear this is a field constantly looking to the future and how we can do more to reduce the global burden of infectious diseases. We look forward toECCMID 2018to find out where we’re heading next.
Related blogs:
Assessing real-time Zika risk in the United States
Comments